Pictet Asset Management Holding Sa Krystal Biotech, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 112,089 shares of KRYS stock, worth $21.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
112,089
Previous 115,350
2.83%
Holding current value
$21.2 Million
Previous $21 Million
16.29%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$747 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$545 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$497 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$242 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$166 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.86B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...